1832 Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23,700	Closed	-$7.11M	–	737
2024 Q3	$7.11M	Buy	+23,700	New	+$7.26M	0.01%	370
2023 Q3	–	Sell	-5	Closed	-$1.91K	–	924
2023 Q2	$1.91K	Buy	+5	New	+$1.79K	﹤0.01%	817
2022 Q2	–	Sell	-753	Closed	-$305K	–	969
2022 Q1	$305K	Buy	+753	New	+$295K	﹤0.01%	691
2021 Q4	–	Sell	-523	Closed	-$228K	–	873
2021 Q3	$228K	Buy	+523	New	+$220K	﹤0.01%	668
2020 Q4	–	Sell	-482,200	Closed	-$133M	–	752
2020 Q3	$133M	Buy	482,200 +65,400	+16%	+$17.3M	0.35%	85
2020 Q2	$92.5M	Buy	+416,800	New	+$81.9M	0.28%	94
2019 Q1	–	Sell	-878,420	Closed	-$86.1M	–	719
2018 Q4	$86.1M	Buy	878,420 +2,400	+0.3%	+$260K	0.34%	74
2018 Q3	$108M	Buy	876,020 +217,460	+33%	+$24.4M	0.35%	72
2018 Q2	$65.4M	Sell	658,560 -143,470	-18%	-$13.2M	0.22%	103
2018 Q1	$71.2M	Buy	802,030 +88,670	+12%	+$8.29M	0.26%	95
2017 Q4	$70.1M	Buy	713,360 +65,390	+10%	+$6.41M	0.23%	96
2017 Q3	$60.5M	Buy	647,970 +372,070	+135%	+$33.7M	0.21%	96
2017 Q2	$26.1M	Buy	275,900 +166,200	+152%	+$15.3M	0.12%	163
2017 Q1	$8.97M	Buy	+109,700	New	+$9.17M	0.03%	267